{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:40:38Z","timestamp":1787316038721,"version":"build-2736575974"},"reference-count":10,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Summary:<\/jats:title>\n                  <jats:p>This article presents a novel computational tool, \u201cBoneMarrowMap,\u201d that enables the mapping of leukemic single-cell RNA sequencing datasets to hematopoietic differentiation states. By utilizing BoneMarrowMap for a large-scale single-cell RNA sequencing reanalysis, the authors discover 12 recurrent acute myeloid leukemia differentiation patterns linked to prognosis and treatment and dissect leukemic clonal architectures within individual patients.<\/jats:p>\n                  <jats:p>See related article by Zeng and colleagues, p. 307<\/jats:p>","DOI":"10.1158\/2643-3230.bcd-25-0083","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:01:55Z","timestamp":1745852515000},"page":"280-283","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Putting AML Differentiation States on the BoneMarrowMap"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6349-0613","authenticated-orcid":false,"given":"Jonas","family":"Berger","sequence":"first","affiliation":[{"name":"1Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow Klinikum, Berlin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-0207","authenticated-orcid":false,"given":"Livius","family":"Penter","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow Klinikum, Berlin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."},{"name":"2Berlin Institute of Health at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charit\u00e9 Digital Clinician Scientist Program, Berlin, Germany."},{"name":"3German Cancer Consortium (DKTK), Partner Site Berlin, a Partnership Between DKFZ and Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"2025070103073712800_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/2643-3230.BCD-24-0342","article-title":"Single-cell transcriptional mapping reveals genetic and hierarchy-based determinants of aberrant differentiation in AML","volume":"6","author":"Zeng","year":"2025","journal-title":"Blood Cancer Discov"},{"key":"2025070103073712800_bib2","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in Acute Myeloid Leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat Commun"},{"key":"2025070103073712800_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"key":"2025070103073712800_bib4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"2025070103073712800_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.stem.2023.04.001","article-title":"Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia","volume":"30","author":"Beneyto-Calabuig","year":"2023","journal-title":"Cell Stem Cell"},{"key":"2025070103073712800_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41467-023-44137-7","article-title":"Integrative genotyping of cancer and immune phenotypes by long-read sequencing","volume":"15","author":"Penter","year":"2024","journal-title":"Nat Commun"},{"key":"2025070103073712800_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ncb3493","article-title":"Human haematopoietic stem cell lineage commitment is a continuous process","volume":"19","author":"Velten","year":"2017","journal-title":"Nat Cell Biol"},{"key":"2025070103073712800_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"},{"key":"2025070103073712800_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1158\/2643-3230.BCD-23-0138","article-title":"Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations","volume":"5","author":"Penter","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"2025070103073712800_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-25-0083\/3598983\/bcd-25-0083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/6\/4\/280\/3625979\/bcd-25-0083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/6\/4\/280\/3625979\/bcd-25-0083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:07:46Z","timestamp":1751339266000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/6\/4\/280\/763149\/Putting-AML-Differentiation-States-on-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,28]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-25-0083","relation":{},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}